Compass Pathways Phase 3 Psilocybin trial results - Psychedelic Stock down 50%?! Emergency podcast!

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/ab/08/66/ab08667b-376d-4202-d812-c044efc84a4f/mza_15113347964605507548.jpg/600x600bb.jpg

Human 3 with Brom and Sam

Brom Rector and Sam Tabone

32 episodes

5 days ago

Interviews with the scientists, founders and investors driving Human 3 - the next epoch of health, wellbeing and performance. Topics include brain-computer interfaces, genetic medicine, psychedelics, longevity, AI and more. Hosted by Brom Rector and Sam Tabone - founders of XEIA Venture Partners, a venture capital fund investing in Human 3. More at www.xeiavp.com

Technology

RSS

All content for Human 3 with Brom and Sam is the property of Brom Rector and Sam Tabone and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Technology

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/13191439/13191439-1750746838140-f8f64e03cee19.jpg

Compass Pathways Phase 3 Psilocybin trial results - Psychedelic Stock down 50%?! Emergency podcast!

Human 3 with Brom and Sam

43 minutes 16 seconds

4 months ago

Compass Pathways Phase 3 Psilocybin trial results - Psychedelic Stock down 50%?! Emergency podcast!

Compass Pathways ($CMPS) released an interim readout from their Phase 3 trial of Psilocybin (COMP360) for treatment resistant depression (TRD).

The data was positive and highly anticipated by the psychedelic community, but the stock dropped 50% on June 23rd. Brom Rector and Sam Tabone of XEIA Venture Partners react and comment in this emergency podcast.

We discuss:

(0:00) - what did the Compass Pathways data readout actually say

(12:00) - putting the Compass trial results into context vs SSRIs, Lexapro, Spravato and Ketamine

(19:00) - why Compass crashed

(24:00) - will Comp360 get FDA approval?

(26:00) - will COMP360 be commercially successful?

(30:00) - price targets for Compass Pathways $CMPS

(35:00) - will Compass get acquired?

(40:00) - are we bullish or bearish on Compass?

Learn more about Brom, Sam and XEIA at www.xeiavp.com